048870.Kq
The company operates in the healthcare services and equipment industry, primarily generating revenue through the production and distribution of medical equipment and supplies.
Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the production and distribution of medical equipment and supplies.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, primarily generating revenue through the production and distribution of medical equipment and supplies.
The company maintains a strong liquidity position, with a current ratio of 3.56, indicating that it has sufficient current assets to cover its current liabilities more than three times over. However, the liquidity risk is assessed as medium, suggesting that while the company is not in immediate distress, it may face challenges in maintaining this level under stress conditions. The debt-to-equity ratio of 0.17 indicates a conservative capital structure, with a relatively low proportion of debt compared to equity.
In terms of profitability, the company's return on equity (ROE) is 1.42%, and its return on assets (ROA) is 0.89%. These figures are below the typical thresholds for strong performance in the healthcare equipment and supplies industry, suggesting that the company is not generating returns at a level that would be considered robust by industry standards. The operating income of 19,029,731,550 KRW and net income of 3,011,341,240 KRW indicate that the company is profitable, but the margins are relatively thin.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification may expose the company to higher risk if demand in its primary market fluctuates. The company's capital expenditure of -5,370,436,900 KRW suggests that it is not investing heavily in new assets, which may limit its ability to grow or modernize its operations.
Looking ahead, the company's growth trajectory is expected to be modest, with no significant revenue growth projected in the next fiscal year. The company's free cash flow of 9,659,911,640 KRW provides some flexibility for reinvestment or shareholder returns, but the lack of capital expenditure may constrain future growth. The company's operating cash flow of 14,777,578,740 KRW supports its current operations and debt obligations, but it is not generating excess cash for aggressive expansion.
The risk assessment indicates that the company faces a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may need to manage its cash flow carefully to avoid liquidity issues. The dilution risk is low, indicating that the company is not expected to issue a significant number of new shares in the near term, which is a positive sign for existing shareholders.
Recent events, as disclosed in the company's financial statements, include a focus on maintaining operational efficiency and managing debt levels. The company has not reported any major new product launches or strategic acquisitions in the latest reporting period, which may indicate a conservative approach to growth.
- The company has a strong current ratio of 3.56, indicating good short-term liquidity.
- The company's ROE of 1.42% and ROA of 0.89% are below industry norms, suggesting suboptimal returns.
- The company's revenue is concentrated in a single business segment, increasing exposure to market fluctuations.
- The company's capital expenditure is negative, indicating a lack of investment in new assets.
- The company's liquidity risk is assessed as medium, and its dilution risk is low.
- The company's free cash flow of 9,659,911,640 KRW provides some flexibility for reinvestment or shareholder returns.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 048870.KQ Market data — financials · 2026-05-26